![[(4aR)-1-(4-Fluorophenyl)-1,4,5,6,7,8-hexahydro-6-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]-4aH-pyrazol…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F497500-4ar-1-4-fluorophenyl-145678-hexahydro-6-1-methyl-1h-pyrazol-4-yl-sulfonyl-4ah-pyrazolo-34-g-isoquinolin-4a-yl-4-trifluoromethyl-2-pyridinyl-methanone.webp&w=3840&q=75)
CAS 1496510-51-0: [(4aR)-1-(4-Fluorophenyl)-1,4,5,6,7,8-hexahydro-6-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]-4aH-pyrazolo[3,4-g]isoquinolin-4a-yl][4-(trifluoromethyl)-2-pyridinyl]methanone
Formula:C27H22F4N6O3S
InChI:InChI=1S/C27H22F4N6O3S/c1-35-15-22(14-33-35)41(39,40)36-9-7-18-11-24-17(13-34-37(24)21-4-2-20(28)3-5-21)12-26(18,16-36)25(38)23-10-19(6-8-32-23)27(29,30)31/h2-6,8,10-11,13-15H,7,9,12,16H2,1H3/t26-/m0/s1
InChI key:InChIKey=WANIDIGFXJFFEL-SANMLTNESA-N
SMILES:C(=O)([C@@]12C(=CC3=C(C1)C=NN3C4=CC=C(F)C=C4)CCN(S(=O)(=O)C5=CN(C)N=C5)C2)C6=CC(C(F)(F)F)=CC=N6
Synonyms:- [(4aR)-1-(4-Fluorophenyl)-1,4,5,6,7,8-hexahydro-6-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]-4aH-pyrazolo[3,4-g]isoquinolin-4a-yl][4-(trifluoromethyl)-2-pyridinyl]methanone
- [(4aR)-1-(4-fluorophenyl)-6-(1-methyl-1H-pyrazole-4-sulfonyl)-1,4,5,6,7,8hexahydro-4aH-pyrazolo[3,4-g]isoquinolin-4a-yl][4-(trifluoromethyl)pyridin-2-yl]methanone
- Relacorilant
- Methanone, [(4aR)-1-(4-fluorophenyl)-1,4,5,6,7,8-hexahydro-6-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]-4aH-pyrazolo[3,4-g]isoquinolin-4a-yl][4-(trifluoromethyl)-2-pyridinyl]-
- CORT 125134
Sort by
Found 2 products.
Relacorilant
CAS:Relacorilant is an oral glucocorticoid receptor antagonist with Ki of 7.2 nM, potential for treating Cushing's syndrome.Formula:C27H22F4N6O3SPurity:98.53% - 99%Color and Shape:SolidMolecular weight:586.56Ref: TM-T16727
1mg111.00€5mg268.00€10mg425.00€25mg710.00€50mg998.00€100mg1,349.00€1mL*10mM (DMSO)340.00€Relacorilant
CAS:Relacorilant is a drug that inhibits the production of epidermal growth factor (EGF). This drug has been shown to be effective in the treatment of adrenocortical carcinoma. Relacorilant is given to patients in a dose-dependent manner, with low doses being more effective than high doses. Relacorilant has been shown to have an anti-tumor effect in vitro and in vivo, which may be due to its inhibition of EGFR activity on cell signaling pathways.Formula:C27H22F4N6O3SPurity:Min. 95%Molecular weight:586.6 g/mol
